SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-23-000136
Filing Date
2023-02-16
Accepted
2023-02-16 16:08:49
Documents
58
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K enzn-20221231x10k.htm   iXBRL 10-K 803837
2 EX-4.1 enzn-20221231xex4d1.htm EX-4.1 40476
3 EX-21.1 enzn-20221231xex21d1.htm EX-21.1 3749
4 EX-23.1 enzn-20221231xex23d1.htm EX-23.1 5289
5 EX-31.1 enzn-20221231xex31d1.htm EX-31.1 11105
6 EX-32.1 enzn-20221231xex32d1.htm EX-32.1 7237
  Complete submission text file 0001410578-23-000136.txt   3754118

Data Files

Seq Description Document Type Size
7 EX-101.SCH enzn-20221231.xsd EX-101.SCH 36550
8 EX-101.CAL enzn-20221231_cal.xml EX-101.CAL 28986
9 EX-101.DEF enzn-20221231_def.xml EX-101.DEF 135876
10 EX-101.LAB enzn-20221231_lab.xml EX-101.LAB 289310
11 EX-101.PRE enzn-20221231_pre.xml EX-101.PRE 226827
52 EXTRACTED XBRL INSTANCE DOCUMENT enzn-20221231x10k_htm.xml XML 383459
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 23638597
SIC: 2836 Biological Products, (No Diagnostic Substances)